GLAND PHARMA
Back to Income Statement
|
GLAND PHARMA Last 5 Year Earnings Per Share (EPS) History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Adjusted EPS | ₹42.40 | ₹46.90 | ₹47.42 | ₹73.75 | ₹60.94 |
What is the latest Earnings Per Share (EPS) of GLAND PHARMA ?
| Year | Earnings Per Share (EPS) |
|---|---|
| Mar2026 | ₹42.40 |
| Mar2025 | ₹46.90 |
| Mar2024 | ₹47.42 |
| Mar2023 | ₹73.75 |
| Mar2022 | ₹60.94 |
How is Earnings Per Share (EPS) of GLAND PHARMA Trending?
| Years | Earnings Per Share (EPS) | % Change | |
|---|---|---|---|
| Mar2026 | ₹42.40 | -9.59 | |
| Mar2025 | ₹46.90 | -1.10 | |
| Mar2024 | ₹47.42 | -35.70 | |
| Mar2023 | ₹73.75 | 21.02 | |
| Mar2022 | ₹60.94 | - | |
Compare Earnings Per Share (EPS) of peers of GLAND PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLAND PHARMA | ₹49,613.9 Cr | 0.6% | 3.5% | 44.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹432,120.0 Cr | -3.2% | -5.4% | 12% | Stock Analytics | |
| DIVIS LABORATORIES | ₹253,390.0 Cr | 0.7% | 3.2% | 61.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹181,740.0 Cr | -2.8% | -3% | 32.6% | Stock Analytics | |
| CIPLA | ₹108,497.0 Cr | -2.9% | -3.3% | -10.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,925.0 Cr | -3.3% | 4.7% | -2.2% | Stock Analytics | |
GLAND PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLAND PHARMA | 0.6% |
3.5% |
44.8% |
| SENSEX | -2.1% |
-5.9% |
-10.8% |
You may also like the below Video Courses